Surgery Partners
SGRY
Surgery Partners (SGRY) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Maintained | Overweight | $18.00 | Aug 11, 2026 |
| RBC Capital | Maintained | Outperform | $19.00 from $20.00 | Aug 11, 2026 |
| TD Cowen | Maintained | Buy | $19.00 from $17.00 | Aug 11, 2026 |
| Mizuho | Maintained | Outperform | $17.00 from $19.00 | Mar 5, 2026 |
| UBS | Maintained | Buy | $21.00 from $29.00 | Mar 5, 2026 |
| TD Cowen | Maintained | Buy | $20.00 from $28.00 | Mar 5, 2026 |
| RBC Capital | Maintained | Outperform | $20.00 from $31.00 | Mar 4, 2026 |
| Barclays | Maintained | Equal-Weight | $14.00 from $18.00 | Mar 3, 2026 |
| Mizuho | Maintained | Outperform | $19.00 from $22.00 | Dec 18, 2025 |
| JP Morgan | Maintained | Neutral | $20.00 from $27.00 | Nov 24, 2025 |
| Barclays | Maintained | Equal-Weight | $18.00 from $24.00 | Nov 21, 2025 |
| Mizuho | Maintained | Outperform | $22.00 from $28.00 | Nov 17, 2025 |
| UBS | Maintained | Buy | $29.00 from $34.00 | Nov 13, 2025 |
| Benchmark | Maintained | Buy | $30.00 from $35.00 | Nov 11, 2025 |
| RBC Capital | Maintained | Outperform | $31.00 from $35.00 | Nov 11, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $36.00 | Oct 7, 2025 |
| JP Morgan | Initiated Coverage | Neutral | $27.00 | Sep 18, 2025 |
| Barclays | Maintained | Equal-Weight | $24.00 from $25.00 | May 27, 2025 |
| Benchmark | Maintained | Buy | $35.00 | Apr 21, 2025 |
| RBC Capital | Maintained | Outperform | $35.00 | Mar 25, 2025 |
Frequently asked questions
What is the latest analyst rating on SGRY?
On Aug 11, 2026, Cantor Fitzgerald maintained Surgery Partners at Overweight with a price target of $18.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.